{[ promptMessage ]}

Bookmark it

{[ promptMessage ]}

PSYC1001HW328.pdf - Instructions Click the link to read the...

Info iconThis preview shows pages 1–2. Sign up to view the full content.

View Full Document Right Arrow Icon
157. Award: 1.00 point Problems? Adjust credit for all students. Required information Instructions: Click the link to read the related article. Then, review the synopsis below and answer the related questions. http://www.nytimes.com/2015/06/05/business/panel-backs-a-drug-to-increase-womens-sex- drive.html Synopsis: An advisory panel of the Food and Drug Administration recently voted 18-6 to recommend approval of a drug, flibanserin, aimed at treating hypoactive sexual desire in women. This drug has been referred to as Viagra’s counterpart for women. The recommendation came after much controversy. Women’s rights groups have claimed that making the drug available to the 7% of women who are affected by hypoactive sexual desire is an important step in the direction of sexual equality. The drug is intended to be used in cases of lack of sexual desire in which relationship problems or a related medical condition are not considered to be causal factors. The drug was previously denied
Background image of page 1

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full Document Right Arrow Icon
Image of page 2
This is the end of the preview. Sign up to access the rest of the document.

{[ snackBarMessage ]}